- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 25, 2025 | 238.68M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 241M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 243M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 245M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 247M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $765M |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $750M |
| Dividends Paid | Q3 2025 · Mar 31, 2025 | $374M |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $377M |
| Capex | Q3 2025 · Mar 31, 2025 | $315M |
| Capex | Q3 2025 · Mar 31, 2024 | $318M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | $870M |
| Operating Cash Flow restated | Q3 2025 · Mar 31, 2024 | $1.68B |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $3.33B |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $5.13B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$2.95B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$3.21B |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $36.66B |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $35.64B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $34.6B |
| Current Assets | Q3 2025 · Jun 30, 2024 | $34.88B |
| Total Assets | Q3 2025 · Mar 31, 2025 | $49.87B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $45.12B |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $1.32B |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $3.9B |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $1.27B |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $3.72B |
| Net Income | Q3 2025 · Mar 31, 2025 | $506M |
| Net Income | Q3 2025 · Mar 31, 2025 | $1.32B |
| Net Income restated | Q3 2025 · Mar 31, 2024 | $261M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | $617M |
| Operating Income | Q3 2025 · Mar 31, 2025 | $730M |
| Operating Income | Q3 2025 · Mar 31, 2025 | $1.85B |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | $369M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | $842M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $2.12B |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $5.97B |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $1.94B |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $5.53B |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $52.76B |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $156.45B |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $52.93B |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $161.43B |
| Revenue | Q3 2025 · Mar 31, 2025 | $54.88B |
| Revenue | Q3 2025 · Mar 31, 2025 | $162.42B |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $54.87B |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $166.96B |